Table 4.
Hazard ratio, 95% confidence limits and p-value for predictors of ICH, shown in univariate, and after adjustment in incremental regression models; and final estimates from the most parsimonious model (also adjusted for age, race and age-race interaction)
Univariate effects |
Adjustment for age-race |
Further adjustment for sex |
Further adjustment for SBP |
Further adjustment for warfarin use |
Most parsimonious model |
||
---|---|---|---|---|---|---|---|
Age (10 year) | Because of age-race interactions, estimates in these models is provided in Table 3 | ||||||
Black Race | |||||||
Male Sex | 2.83 (1.63 – 4.91) 0.0003 |
2.75 (1.60 – 4.73) 0.0003 |
2.60 (1.50 – 4.48) 0.0007 |
||||
Region | Belt | 0.71 (0.41 – 1.23) 0.22 |
0.74 (0.43 – 1.27) 0.28 |
0.76 (0.44 – 1.32) 0.33 |
0.75 (0.43 – 1.30) 0.31 |
0.76 (0.44 – 1.31) 0.32 |
|
Buckle | 0.90 (0.47 – 1.70) 0.74 |
0.94 (0.49 – 1.78) 0.84 |
1.01 (0.53 – 1.93) 0.77 |
1.01 (0.53 – 1.94) 0.97 |
1.01 (0.53 – 1.93) 0.97 |
||
Hypertension | 1.57 (0.91 – 2.68) 0.10 |
1.35 (0.78 – 2.34) 0.28 |
1.38 (0.80 – 2.38) 0.25 |
1.08 (0.59 – 1.98) 0.78 |
1.06 (0.58 – 1.94) 0.85 |
||
SBP (10 mmHg) | 1.24 (1.10 – 1.40) 0.0003 |
1.20 (1.06 – 1.36) 0.0053 |
1.18 (1.04 – 1.35) 0.011 |
1.19 (1.04 – 1.36) 0.0089 |
|||
Diabetes | 1.28 (0.70 – 2.33) 0.43 |
1.29 (0.71 – 2.33) 0.40 |
1.23 (0.68 – 2.22) 0.50 |
1.17 (0.64 – 2.12) 0.61 |
1.14 (0.63 – 2.08) 0.66 |
||
CKD | 2.26 (1.28 – 3.98) 0.0052 |
1.75 (0.98 – 3.13) 0.058 |
1.74 (0.97 – 3.10) 0.062 |
1.59 (0.89 – 2.86) 0.12 |
1.54 (0.85 – 2.77) 0.15 |
||
Total Chol (10 mg/dL) | 0.95 (0.89 – 1.01) 0.12 |
0.96 (0.90 – 1.03) 0.28 |
0.99 (0.93 – 1.06) 0.82 |
0.99 (0.92 – 1.05) 0.70 |
0.99 (0.93 – 1.06) 0.75 |
||
LN(Trig) | 0.82 (0.49 – 1.38) 0.45 |
0.84 (0.49 – 1.44) 0.52 |
0.84 (0.50 – 1.43) 0.53 |
0.80 (0.47 – 1.36) 0.41 |
0.79 (0.46 – 1.34) 0.38 |
||
HDL (10 mg/dL) | 0.87 (0.75 – 1.02) 0.098 |
0.87 (0.74 – 1.02) 0.090 |
0.97 (0.82 – 1.15) 0.76 |
0.98 (0.83 – 1.15) 0.78 |
0.98 (0.83 – 1.16) 0.84 |
||
LDL (10 mg/dL) | 0.97 (0.91 – 1.05) 0.49 |
0.99 (0.92 – 1.07) 0.83 |
1.00 (0.93 – 1.08) 0.90 |
1.00 (0.93 – 1.08) 1.00 |
1.00 (0.93 – 1.08) 0.94 |
||
LN(CRP) | 1.06 (0.84 – 1.32) 0.63 |
1.06 (0.84 – 1.33) 0.60 |
1.14 (0.90 – 1.43) 0.28 |
1.12 (0.89 – 1.41) 0.34 |
1.10 (0.87 – 1.39) 0.43 |
||
Smoking (vs. never-smoking) |
Past | 1.31 (0.77 – 2.21) 0.32 |
1.27 (0.75 – 2.15) 0.37 |
1.04 (0.60 – 1.78) 0.89 |
1.02 (0.60 – 1.75) 0.94 |
1.02 (0.60 – 1.76) 0.93 |
|
Current | 1.22 (0.56 – 2.66) 0.61 |
1.53 (0.69 – 3.40) 0.29 |
1.38 (0.62 – 3.08) 0.43 |
1.32 (0.59 – 2.95) 0.50 |
1.33 (0.59 – 2.99) 0.48 |
||
Smoking (versus non-smoking) | 1.07 (0.51 – 2.25) 0.86 |
1.36 (0.63 – 2.92) 0.43 |
1.35 (0.63 – 2.91) 0.44 |
1.30 (0.60 – 2.82) 0.50 |
1.32 (0.61 – 2.85) 0.48 |
||
Alcohol Use | 1.05 (0.64 – 1.75) 0.84 |
1.16 (0.71 – 1.90) 0.55 |
0.97 (0.59 – 1.61) 0.91 |
0.97 (0.58 – 1.60) 0.89 |
0.97 (0.58 – 1.60) 0.90 |
||
Warfarin use | 3.54 (1.63 – 7.67) 0.0014 |
2.40 (1.08 – 5.33) 0.032 |
2.15 (0.96 – 4.78) 0.062 |
2.24 (1.01 – 5.00) 0.048 |
2.24 (1.01 – 5.00) 0.048 |
||
Aspirin Use | 1.51 (0.87 – 2.59) 0.14 |
1.32 (0.76 – 2.32) 0.32 |
1.19 (0.67 – 2.11) 0.55 |
1.19 (0.67 – 2.10) 0.55 |
1.27 (0.71 – 2.26) 0.41 |
||
NSAID Use | 0.50 (0.17 – 1.43) 0.19 |
0.55 (0.19 – 1.58) 0.26 |
0.63 (0.22 – 1.80) 0.38 |
0.61 (0.21 – 1.77) 0.36 |
0.62 (0.22 – 1.79) 0.38 |